Livforsakringsbolaget Skandia’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-271
| Closed | -$66K | – | 533 |
|
2025
Q1 | $66K | Hold |
271
| – | – | ﹤0.01% | 530 |
|
2024
Q4 | $89K | Hold |
271
| – | – | ﹤0.01% | 508 |
|
2024
Q3 | $90.6K | Buy |
271
+200
| +282% | +$66.9K | ﹤0.01% | 531 |
|
2024
Q2 | $19.4K | Hold |
71
| – | – | ﹤0.01% | 495 |
|
2024
Q1 | $24.5K | Hold |
71
| – | – | ﹤0.01% | 481 |
|
2023
Q4 | $22.9K | Buy |
+71
| New | +$22.9K | ﹤0.01% | 481 |
|
2022
Q3 | – | Sell |
-200
| Closed | -$99K | – | 587 |
|
2022
Q2 | $99K | Sell |
200
-200
| -50% | -$99K | 0.01% | 458 |
|
2022
Q1 | $225K | Hold |
400
| – | – | 0.02% | 441 |
|
2021
Q4 | $302K | Hold |
400
| – | – | 0.02% | 394 |
|
2021
Q3 | $298K | Sell |
400
-100
| -20% | -$74.5K | 0.02% | 440 |
|
2021
Q2 | $322K | Buy |
500
+300
| +150% | +$193K | 0.02% | 463 |
|
2021
Q1 | $114K | Hold |
200
| – | – | 0.01% | 582 |
|
2020
Q4 | $117K | Hold |
200
| – | – | 0.01% | 559 |
|
2020
Q3 | $103K | Hold |
200
| – | – | 0.01% | 533 |
|
2020
Q2 | $90K | Hold |
200
| – | – | 0.01% | 555 |
|
2020
Q1 | $70K | Buy |
+200
| New | +$70K | 0.01% | 545 |
|